Research into attitudes towards starting treatment early

The research for this cornerstone has ended. Starting treatment early is the norm for the large majority of patients and specialists, which means that the objectives of this cornerstone have been achieved.
snelstarten

About the research

The H-TEAM’s research aimed to gain insight into the perceptions of, as well as the motivating and demotivating factors for, starting treatment early (in case of a CD4 count of over 500) among people living with HIV and HIV practitioners.

waarom-w

Why

The potential advantages of starting antiretroviral therapy (ART) early – such as the prevention of health loss and virus transmissions – are largely determined by the willingness of HIV patients and HIV practitioners (to advise) to start treatment in case of a high CD4 count.

Read more >>

aanpakken

Approach

The research comprised interviews with fourteen HIV-positive patients – who had a CD4 count over 500 cells/m3 at the moment of diagnosis – and sixteen HIV practitioners, among whom nine internist-infectious disease specialists and seven HIV counselors.

Read more >>

resultaat-w

Results

The majority of practitioners and patients appeared to feel positive about early treatment, and they quickly started treatment (or advised their patients to do so). The ideas and decision-making processes related to early treatment were influenced by treatment-related factors and patient-related factors.

Read more >>

Team

  • Marijn de Bruin
    Marijn de Bruin

    Member
    UvA

  • Suzanne Geerlings
    Suzanne Geerlings

    Project Leader
    Amsterdam UMC

  • Jan Prins
    Jan Prins

    Project Leader
    Amsterdam UMC